DOI QR코드

DOI QR Code

The role of lysophosphatidic acid receptor 1 in inflammatory response induced by lipopolysaccharide from Porphyromonas gingivalis in human periodontal ligament stem cells

  • Kim, Dong Hee (Department of Oral Biochemistry, Pusan National University School of Dentistry) ;
  • Seo, Eun Jin (Department of Oral Biochemistry, Pusan National University School of Dentistry) ;
  • Tigyi, Gabor J. (Department of Physiology, University of Tennessee Health Science Center) ;
  • Lee, Byung Ju (Department of Biological Sciences, College of Natural Sciences, University of Ulsan) ;
  • Jang, Il Ho (Department of Oral Biochemistry, Pusan National University School of Dentistry)
  • 투고 : 2020.06.16
  • 심사 : 2020.06.22
  • 발행 : 2020.06.30

초록

Lysophosphatidic acid (LPA) is a lipid messenger mediated by G protein-coupled receptors (LPAR1-6). It is involved in the pathogenesis of certain chronic inflammatory and autoimmune diseases. In addition, it controls the self-renewal and differentiation of stem cells. Recent research has demonstrated the close relationship between periodontitis and various diseases in the human body. However, the precise role of LPA in the development of periodontitis has not been studied. We identified that LPAR1 was highly expressed in human periodontal ligament stem cells (PDLSCs). In periodontitis-mimicking conditions with Porphyromonas gingivalis-derived lipopolysaccharide (Pg-LPS) treatment, PDLSCs exhibited a considerable reduction in the cellular viability and osteogenic differentiation potential, in addition to an increase in the inflammatory responses including tumor necrosis factor-α and interleukin-1β expression and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. Of the various LPAR antagonists, pre-treatment with AM095, an LPAR1 inhibitor, showed a positive effect on the restoration of cellular viability and osteogenic differentiation, accompanied by a decrease in NF-κB signaling, and action against Pg-LPS. These findings suggest that the modulation of LPAR1 activity will assist in checking the progression of periodontitis and in its treatment.

키워드

참고문헌

  1. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 2015;15:30-44. doi: 10.1038/nri3785.
  2. Sharpe PT. Dental mesenchymal stem cells. Development 2016;143:2273-80. doi: 10.1242/dev.134189.
  3. Liu J, Yu F, Sun Y, Jiang B, Zhang W, Yang J, Xu GT, Liang A, Liu S. Concise reviews: characteristics and potential applications of human dental tissue-derived mesenchymal stem cells. Stem Cells 2015;33:627-38. doi: 10.1002/stem.1909.
  4. Menicanin D, Mrozik KM, Wada N, Marino V, Shi S, Bartold PM, Gronthos S. Periodontal-ligament-derived stem cells exhibit the capacity for long-term survival, self-renewal, and regeneration of multiple tissue types in vivo. Stem Cells Dev 2014;23:1001-11. doi: 10.1089/scd.2013.0490.
  5. Zhu W, Liang M. Periodontal ligament stem cells: current status, concerns, and future prospects. Stem Cells Int 2015;2015:972313. doi: 10.1155/2015/972313.
  6. Tigyi G. Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol 2010;161:241-70. doi: 10.1111/j.1476-5381.2010.00815.x.
  7. Yung YC, Stoddard NC, Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res 2014;55:1192-214. doi: 10.1194/jlr.R046458.
  8. Sheng X, Yung YC, Chen A, Chun J. Lysophosphatidic acid signalling in development. Development 2015;142:1390-5. doi: 10.1242/dev.121723.
  9. Pebay A, Bonder CS, Pitson SM. Stem cell regulation by lysophospholipids. Prostaglandins Other Lipid Mediat 2007;84:83-97. doi: 10.1016/j.prostaglandins.2007.08.004.
  10. Kim BC, Song JI, So KH, Hyun SH. Effects of lysophosphatidic acid on human periodontal ligament stem cells from teeth extracted from dental patients. J Biomed Res 2019;33:122-30. doi: 10.7555/JBR.32.20170123.
  11. Chen X, Walther FJ, Laghmani EH, Hoogeboom AM, Hogen-Esch AC, van Ark I, Folkerts G, Wagenaar GT. Adult lysophosphatidic acid receptor 1-deficient rats with hyperoxiainduced neonatal chronic lung disease are protected against lipopolysaccharide-induced acute lung injury. Front Physiol 2017;8:155. doi: 10.3389/fphys.2017.00155.
  12. Li HY, Oh YS, Choi JW, Jung JY, Jun HS. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice. Kidney Int 2017;91:1362-73. doi: 10.1016/j.kint.2016.11.010.
  13. Gonzalez-Gil I, Zian D, Vazquez-Villa H, Hernandez-Torres G, Martinez RF, Khiar-Fernandez N, Rivera R, Kihara Y, Devesa I, Mathivanan S, Del Valle CR, Zambrana-Infantes E, Puigdomenech M, Cincilla G, Sanchez-Martinez M, Rodriguez de Fonseca F, Ferrer-Montiel AV, Chun J, Lopez-Vales R, Lopez-Rodriguez ML, Ortega-Gutierrez S. A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration. J Med Chem 2020;63:2372-90. doi: 10.1021/acs.jmedchem.9b01287.
  14. Tomokiyo A, Yoshida S, Hamano S, Hasegawa D, Sugii H, Maeda H. Detection, characterization, and clinical application of mesenchymal stem cells in periodontal ligament tissue. Stem Cells Int 2018;2018:5450768. doi: 10.1155/2018/5450768.
  15. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, Young M, Robey PG, Wang CY, Shi S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-55. doi: 10.1016/S0140-6736(04)16627-0.
  16. Guihard P, Danger Y, Brounais B, David E, Brion R, Delecrin J, Richards CD, Chevalier S, Redini F, Heymann D, Gascan H, Blanchard F. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 2012;30:762-72. doi: 10.1002/stem.1040.
  17. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 2011;6:457-78. doi: 10.1146/annurev-pathol-011110-130230.
  18. Chen X, Hu C, Wang G, Li L, Kong X, Ding Y, Jin Y. Nuclear factor-$\kappa$B modulates osteogenesis of periodontal ligament stem cells through competition with $\beta$-catenin signaling in inflammatory microenvironments. Cell Death Dis 2013;4:e510. doi: 10.1038/cddis.2013.14.
  19. Nsaibia MJ, Boulanger MC, Bouchareb R, Mkannez G, Le Quang K, Hadji F, Argaud D, Dahou A, Bosse Y, Koschinsky ML, Pibarot P, Arsenault BJ, Marette A, Mathieu P. OxLDLderived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-$\kappa$B pathway. Cardiovasc Res 2017;113:1351-63. doi: 10.1093/cvr/cvx089.